KR900005050B1 - 6-beta (substituted)-(s)-hydroxymethyl-penicillanic acids and derivatives thereof - Google Patents

6-beta (substituted)-(s)-hydroxymethyl-penicillanic acids and derivatives thereof

Info

Publication number
KR900005050B1
KR900005050B1 KR8800565A KR880000565A KR900005050B1 KR 900005050 B1 KR900005050 B1 KR 900005050B1 KR 8800565 A KR8800565 A KR 8800565A KR 880000565 A KR880000565 A KR 880000565A KR 900005050 B1 KR900005050 B1 KR 900005050B1
Authority
KR
South Korea
Prior art keywords
beta
hydroxymethyl
derivatives
substituted
penicillanic acids
Prior art date
Application number
KR8800565A
Other languages
English (en)
Other versions
KR880009030A (ko
Inventor
Riang-Chen Yuping
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of KR880009030A publication Critical patent/KR880009030A/ko
Application granted granted Critical
Publication of KR900005050B1 publication Critical patent/KR900005050B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/86—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with only atoms other than nitrogen atoms directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR8800565A 1987-01-27 1988-01-26 6-beta (substituted)-(s)-hydroxymethyl-penicillanic acids and derivatives thereof KR900005050B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US731987A 1987-01-27 1987-01-27
US007319 1987-01-27

Publications (2)

Publication Number Publication Date
KR880009030A KR880009030A (ko) 1988-09-13
KR900005050B1 true KR900005050B1 (en) 1990-07-19

Family

ID=21725481

Family Applications (1)

Application Number Title Priority Date Filing Date
KR8800565A KR900005050B1 (en) 1987-01-27 1988-01-26 6-beta (substituted)-(s)-hydroxymethyl-penicillanic acids and derivatives thereof

Country Status (25)

Country Link
EP (1) EP0276942B1 (ko)
JP (1) JPS63246384A (ko)
KR (1) KR900005050B1 (ko)
CN (1) CN1014710B (ko)
AT (1) ATE74359T1 (ko)
AU (2) AU590142B2 (ko)
CA (1) CA1288091C (ko)
DD (1) DD279882A5 (ko)
DE (1) DE3869630D1 (ko)
DK (1) DK36788A (ko)
ES (1) ES2031589T3 (ko)
FI (1) FI880334A (ko)
GR (1) GR3004460T3 (ko)
HU (1) HU205765B (ko)
IE (1) IE60348B1 (ko)
IL (1) IL85167A (ko)
MY (1) MY102312A (ko)
NO (1) NO172493C (ko)
NZ (1) NZ223296A (ko)
PH (1) PH24478A (ko)
PL (2) PL161601B1 (ko)
PT (1) PT86613B (ko)
SU (2) SU1591812A3 (ko)
YU (2) YU46436B (ko)
ZA (1) ZA88514B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2031589T3 (es) * 1987-01-27 1992-12-16 Pfizer Inc. Acidos 6-beta-(sustituyente)-(s)-hidroximetil-penicilanicos y sus derivados.
AU5617398A (en) * 1996-12-30 1998-07-31 Beacon Laboratories L.L.C. Tricarboxylic acid-containing oxyalkyl esters and uses thereof
GB0128052D0 (en) * 2001-11-22 2002-01-16 Drug Discovery Lab As Compounds
US8187727B2 (en) 2005-07-22 2012-05-29 Lg Chem, Ltd. Imidazole derivatives, preparation method thereof and organic electronic device using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4272439A (en) * 1978-06-02 1981-06-09 Schering Corporation 6-(Substituted-hydroxymethylene penams)
US4304779A (en) * 1979-05-09 1981-12-08 Schering Corporation 6-(Nitrogen-containing heterocyclic)hydroxymethylpenicillanic acids, compounds related thereto and processes for their preparation
US4287181A (en) * 1979-10-22 1981-09-01 Pfizer Inc. Derivatives of 6β-hydroxyalkylpenicillanic acids as β-lactamase inhibitors
EP0083977A1 (en) * 1982-01-11 1983-07-20 Pfizer Inc. 6-Alpha-hydroxymethylpenicillanic acid sulfone as a beta-lactamase inhibitor
EP0150984B1 (en) * 1984-01-30 1991-09-11 Pfizer Inc. 6-(substituted) methylenepenicillanic and 6-(substituted) hydroxymethylpenicillanic acids and derivatives thereof
ES8604972A1 (es) * 1984-01-30 1986-02-16 Pfizer Un procedimiento para la preparacion de acidos 6-metilen-(sustituido) penicilanicos y derivados de los mismos.
ES2031589T3 (es) * 1987-01-27 1992-12-16 Pfizer Inc. Acidos 6-beta-(sustituyente)-(s)-hidroximetil-penicilanicos y sus derivados.

Also Published As

Publication number Publication date
AU590142B2 (en) 1989-10-26
PL161601B1 (pl) 1993-07-30
IE880197L (en) 1988-07-27
JPS63246384A (ja) 1988-10-13
NO880297L (no) 1988-07-28
PL159842B1 (pl) 1993-01-29
YU14488A (en) 1990-02-28
AU4883290A (en) 1990-05-17
YU47020B (sh) 1994-11-15
EP0276942B1 (en) 1992-04-01
IL85167A0 (en) 1988-07-31
FI880334A (fi) 1988-07-28
NO172493B (no) 1993-04-19
NO880297D0 (no) 1988-01-25
HU205765B (en) 1992-06-29
DE3869630D1 (de) 1992-05-07
ES2031589T3 (es) 1992-12-16
NO172493C (no) 1993-07-28
CA1288091C (en) 1991-08-27
YU124389A (en) 1990-12-31
PT86613B (pt) 1991-12-31
IL85167A (en) 1994-01-25
PL270301A1 (en) 1988-12-08
ATE74359T1 (de) 1992-04-15
IE60348B1 (en) 1994-06-29
MY102312A (en) 1992-05-28
PT86613A (pt) 1988-02-01
AU613821B2 (en) 1991-08-08
YU46436B (sh) 1993-10-20
SU1681730A3 (ru) 1991-09-30
GR3004460T3 (ko) 1993-03-31
EP0276942A1 (en) 1988-08-03
AU1074388A (en) 1988-07-28
FI880334A0 (fi) 1988-01-26
CN88100588A (zh) 1988-08-10
DD279882A5 (de) 1990-06-20
KR880009030A (ko) 1988-09-13
DK36788A (da) 1988-09-23
HUT47118A (en) 1989-01-30
PH24478A (en) 1990-07-18
CN1014710B (zh) 1991-11-13
DK36788D0 (da) 1988-01-26
SU1591812A3 (ru) 1990-09-07
NZ223296A (en) 1989-10-27
ZA88514B (en) 1989-09-27

Similar Documents

Publication Publication Date Title
IE781140L (en) Penicillanic acid s-oxides
EP0537802A3 (en) N-acylpyrrolidines and n-acylthiazolidines, process for their preparation and their use for prevention and/or treatment of amnesia
ES2001794A6 (es) Un procedimiento para la preparacion de derivados de quinolina
ES8606360A1 (es) Un derivado de cefalosporina.
KR900005050B1 (en) 6-beta (substituted)-(s)-hydroxymethyl-penicillanic acids and derivatives thereof
KR970702723A (ko) 베타-락탐 항생 물질과 조합하여 베타-락타마아제를 억제하는 페넴을 함유하는 약제학적 제형물 및 박테리아 감염의 치료에서 상기 제형물을 사용하는 방법(pharmaceutical formulations containing a beta-lactamase inhibiting penem in combination with a beta-lactam antibiotic and their use in the treatment of bacterial infections)
ES8103094A1 (es) Un procedimiento para la preparacion de 1,1-dioxido de acidopenicilanico y esteres del mismo
AU8309287A (en) Penem derivatives, production and use thereof
AU2037188A (en) 7-(2-methyl-4-aminopyrrolidinyl) 4-oxo-naphthyridine and quinoline derivatives
EP0280240A3 (en) Cephalosporin derivatives, process for their preparation and antibacterial agents
ES476259A1 (es) Un procedimiento para la preparacion de un compuesto.
TW371304B (en) Cephem compounds having antibacterial activity, their production and pharmaceutical composition
ES469922A1 (es) Un procedimiento para la preparacion de un derivado del 1,1-dioxido del acido penicilanico

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19930514

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee